WO2000060066A8 - Protein-protein from s. cerevisiae and methods of using same - Google Patents
Protein-protein from s. cerevisiae and methods of using sameInfo
- Publication number
- WO2000060066A8 WO2000060066A8 PCT/US2000/008399 US0008399W WO0060066A8 WO 2000060066 A8 WO2000060066 A8 WO 2000060066A8 US 0008399 W US0008399 W US 0008399W WO 0060066 A8 WO0060066 A8 WO 0060066A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- complexes
- same
- polypeptide
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000609558A JP2003524400A (en) | 1999-04-01 | 2000-03-30 | S. Cerevisiae-derived protein-protein and methods of using the same |
EP00921513A EP1165772A1 (en) | 1999-04-01 | 2000-03-30 | Protein-protein complexes from s. cerevisiae and methods of using same |
AU41820/00A AU4182000A (en) | 1999-04-01 | 2000-03-30 | Protein-protein from s. cerevisiae and methods of using same |
CA002365548A CA2365548A1 (en) | 1999-04-01 | 2000-03-30 | Protein-protein from s. cerevisiae and methods of using same |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12735299P | 1999-04-01 | 1999-04-01 | |
US60/127,352 | 1999-04-01 | ||
US17896500P | 2000-02-01 | 2000-02-01 | |
US60/178,965 | 2000-02-01 | ||
US09/538,092 US6753314B1 (en) | 1999-04-01 | 2000-03-29 | Protein-protein complexes and methods of using same |
US09/538,092 | 2000-03-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000060066A1 WO2000060066A1 (en) | 2000-10-12 |
WO2000060066A8 true WO2000060066A8 (en) | 2001-03-22 |
Family
ID=27383564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/008399 WO2000060066A1 (en) | 1999-04-01 | 2000-03-30 | Protein-protein from s. cerevisiae and methods of using same |
Country Status (5)
Country | Link |
---|---|
US (1) | US6753314B1 (en) |
EP (1) | EP1165772A1 (en) |
JP (1) | JP2003524400A (en) |
CA (1) | CA2365548A1 (en) |
WO (1) | WO2000060066A1 (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6995018B1 (en) * | 1999-04-09 | 2006-02-07 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Complex formed by N-linked glycoproteins (SIBLINGS)and Factor H |
US7208581B1 (en) * | 1999-11-05 | 2007-04-24 | The Burnham Institute | TRAF family proteins |
US6936424B1 (en) * | 1999-11-16 | 2005-08-30 | Matritech, Inc. | Materials and methods for detection and treatment of breast cancer |
US7211563B2 (en) * | 2001-04-02 | 2007-05-01 | Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung | Protein disulfide isomerase and ABC transporter homologous proteins involved in the regulation of energy homeostasis |
ATE421693T1 (en) * | 2001-05-29 | 2009-02-15 | Pride Proteomics As | PROTEINS IN DIABETES PROTEOM ANALYSIS |
WO2003025213A2 (en) * | 2001-09-21 | 2003-03-27 | Mds Proteomics Inc. | Yeast proteome analysis |
WO2003033667A2 (en) * | 2001-10-18 | 2003-04-24 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Use of mx gtpases in the prognosis and treatment of cancer |
US20060275747A1 (en) * | 2001-12-07 | 2006-12-07 | Hardy Stephen F | Endogenous retrovirus up-regulated in prostate cancer |
GB0202871D0 (en) * | 2002-02-07 | 2002-03-27 | Cancer Res Ventures Ltd | Assays,methods and means |
US7074893B2 (en) * | 2002-06-03 | 2006-07-11 | Regents Of The University Of Michigan | Methods and compositions for the treatment of diseases associated with signal transduction aberrations |
US20050164201A1 (en) * | 2002-06-10 | 2005-07-28 | Harvey Diane M. | Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses therof |
ATE545651T1 (en) * | 2002-06-13 | 2012-03-15 | Novartis Vaccines & Diagnostic | VECTORS FOR EXPRESSING HML-2 POLYPEPTIDES |
AU2003258127A1 (en) * | 2002-08-06 | 2004-02-23 | Diadexus, Inc. | Compositions and methods relating to ovarian specific genes and proteins |
US20060057147A1 (en) * | 2002-10-04 | 2006-03-16 | Mitsubishi Pharma Corporation | Antibody recognizing antibody |
EP1713930B1 (en) * | 2004-01-17 | 2010-11-03 | Korea Research Institute of Bioscience and Biotechnology | Rapid screening method of translational fusion partners for producing recombinant proteins and translational fusion partners screened therefrom |
CA2560066A1 (en) | 2004-03-01 | 2005-09-15 | The Cbr Institute For Biomedical Research, Inc. | Natural igm antibodies and inhibitors thereof |
US20100136684A1 (en) * | 2004-03-01 | 2010-06-03 | Carroll Michael C | Natural IgM Antibodies |
WO2006013010A2 (en) * | 2004-07-31 | 2006-02-09 | Metanomics Gmbh | Preparation of organisms with faster growth and/or higher yield |
US7485468B2 (en) * | 2004-10-15 | 2009-02-03 | Galapagos Bv | Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases |
US8673268B2 (en) | 2004-10-15 | 2014-03-18 | Galapagos N.V. | Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases |
US7795390B2 (en) * | 2005-06-24 | 2010-09-14 | Teijin Pharma Limited | Biological substance nesfatin and its related substances and uses thereof |
CA2613257A1 (en) * | 2005-06-24 | 2006-12-28 | Teijin Pharma Limited | A novel biological substance nesfatin and its related substances and uses thereof |
AU2007223596B2 (en) * | 2006-03-01 | 2010-07-01 | Suntory Holdings Limited | Gene encoding glycogen synthesis initiator and use thereof |
CA2651800A1 (en) * | 2006-04-24 | 2007-11-08 | Shantha West, Inc. | Agrm2 antigen |
WO2008070179A2 (en) | 2006-12-06 | 2008-06-12 | Monsanto Technology, Llc | Genes and uses for plant improvement |
WO2011021386A1 (en) * | 2009-08-21 | 2011-02-24 | Oncotherapy Science, Inc. | Cstf2 for target genes of lung cancer therapy and diagnosis |
EP2330122A1 (en) | 2009-12-02 | 2011-06-08 | Asklepios Kliniken Hamburg Gmbh | OFA/iLRP derived modified peptide |
KR20130028044A (en) * | 2009-12-08 | 2013-03-18 | 헬스 리서치 인코포레이티드 | Methods and compositions using peroxiredoxin1 (prx1) as an adjuvant |
US20140017748A1 (en) * | 2010-02-12 | 2014-01-16 | Gevo, Inc. | Modified alcohol dehydrogenases for the production of fuels and chemicals |
KR20120129953A (en) | 2010-02-12 | 2012-11-28 | 캘리포니아 인스티튜트 오브 테크놀로지 | Yeast microorganisms with reduced by-product accumulation for improved production of fuels, chemicals, and amino acids |
CA2858350A1 (en) | 2011-01-14 | 2013-07-19 | The Regents Of The University Of California | Therapeutic antibodies against ror-1 protein and methods for use of same |
US9340584B2 (en) | 2011-03-29 | 2016-05-17 | The General Hospital Corporation | Engineered thioredoxin-like fold proteins |
CN102286499A (en) * | 2011-06-16 | 2011-12-21 | 山西农业大学 | CDNA of alpaca hair color formation associated cyclin-dependent kinase 5(CDK5-A) gene |
JP6196034B2 (en) * | 2012-12-20 | 2017-09-13 | ライオン株式会社 | Marker peptide for determining hyperglycemia risk and use thereof |
US9243059B2 (en) | 2013-03-12 | 2016-01-26 | Decimmune Therapeutics, Inc. | Humanized anti-N2 antibodies and methods of treating ischemia-reperfusion injury |
CN103756984B (en) * | 2014-02-18 | 2015-10-14 | 吉林大学 | High vigor Selenoperoxidase GPX2 mutant and preparation method thereof |
CN105693825A (en) * | 2016-04-22 | 2016-06-22 | 南通大学 | Cancer inhibition polypeptide 127aa and expression vector and application thereof |
CN105949305A (en) * | 2016-06-30 | 2016-09-21 | 南通大学 | {0><}0{>Sept2 truncated protamine as well as vector and application thereof |
US11578108B2 (en) * | 2021-03-24 | 2023-02-14 | Chungbuk National University Industrial-Academic Cooperation Foundation | Amphiphysin-I mutant having anti-senescence activity and use thereof |
CN116162644B (en) * | 2022-07-07 | 2024-04-05 | 昆明理工大学 | New application of phenylalanine ammonia lyase gene pal |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020025552A1 (en) | 1998-01-06 | 2002-02-28 | Institut Pasteur | Screening interactor molecules with whole genome oligonucleotide or polynucleotide arrays |
WO2000046406A2 (en) | 1999-02-05 | 2000-08-10 | Alphagene, Inc. | Arrays for investigating protein protein interactions |
-
2000
- 2000-03-29 US US09/538,092 patent/US6753314B1/en not_active Expired - Fee Related
- 2000-03-30 JP JP2000609558A patent/JP2003524400A/en not_active Withdrawn
- 2000-03-30 CA CA002365548A patent/CA2365548A1/en not_active Abandoned
- 2000-03-30 WO PCT/US2000/008399 patent/WO2000060066A1/en not_active Application Discontinuation
- 2000-03-30 EP EP00921513A patent/EP1165772A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2000060066A1 (en) | 2000-10-12 |
JP2003524400A (en) | 2003-08-19 |
US6753314B1 (en) | 2004-06-22 |
CA2365548A1 (en) | 2000-10-12 |
EP1165772A1 (en) | 2002-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000060066A8 (en) | Protein-protein from s. cerevisiae and methods of using same | |
WO1999036550A3 (en) | Human protease molecules | |
CA2295999A1 (en) | Nik proteins, nucleic acids and methods | |
WO1999057311A3 (en) | Novel method for the identification of clones conferring a desired biological property from an expression library | |
WO2001004264A3 (en) | Atherosclerosis-associated genes | |
DK1005540T3 (en) | IKK-beta proteins, nucleic acids and methods | |
PL299053A1 (en) | Amino acid compound being a nucleic acid, vector, host cell, genomic zyme clone, method of diagnozing the alzheimer disease, method of determining and expressing a nucleic acid sequence | |
WO2001012662A3 (en) | Membrane associated proteins | |
WO1999024463A3 (en) | Signal peptide-containing proteins | |
WO2000012726A3 (en) | Rationally designed heparinases derived from heparinase i and ii | |
WO1998021343A8 (en) | Genes encoding telomerase proteins | |
AU6277799A (en) | Il-17 homolog nucleic acids, polypeptides, vectors, host cells, methods and usesthereof | |
WO2000061622A3 (en) | Genes associated with diseases of the kidney | |
WO2004066958A3 (en) | Caspase-9:bir3 domain of xiap complexes and methods of use | |
WO2000021988A3 (en) | Human ankyrin family protein | |
WO2000018922A3 (en) | Human carbohydrate-associated proteins | |
WO2000009709A3 (en) | Proteases and associated proteins | |
WO2003068940A3 (en) | Complexes and methods of using same | |
CA2294566A1 (en) | Ikk-.alpha. proteins, nucleic acids and methods | |
WO2000029448A3 (en) | Human proteins having hydrophobic domains and dnas encoding these proteins | |
WO2000017355A3 (en) | Human cytoskeleton associated proteins | |
WO2001005970A3 (en) | Gtp-binding protein associated factors | |
WO2000052151A3 (en) | Human secretory proteins | |
WO1999033870A3 (en) | Human regulatory proteins | |
WO2000044900A3 (en) | Nucleic-acid binding proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: PAT. BUL. 41/2000 UNDER (30) REPLACE THE EXISTING TEXT BY "60/127352, 01.04.99, US 60/178965, 01.02.2000, US 09/538092, 29.03.2000, US" |
|
ENP | Entry into the national phase |
Ref document number: 2365548 Country of ref document: CA Ref country code: CA Ref document number: 2365548 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 609558 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000921513 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000921513 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000921513 Country of ref document: EP |